GSUKX
Price
$26.17
Change
+$0.29 (+1.12%)
Updated
Aug 21 closing price
Net Assets
3.74B
VIHAX
Price
$50.90
Change
+$0.55 (+1.09%)
Updated
Aug 21 closing price
Net Assets
21.87B
Interact to see
Advertisement

GSUKX vs VIHAX

GSUKX vs VIHAX Comparison Chart in %
View a ticker or compare two or three
VS
GSUKX vs. VIHAX commentary
Aug 23, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GSUKX is a Buy and VIHAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VIHAX has more cash in the bank: 21.9B vs. GSUKX (3.74B). VIHAX pays higher dividends than GSUKX: VIHAX (3.45) vs GSUKX (2.27). GSUKX was incepted earlier than VIHAX: GSUKX (10 years) vs VIHAX (10 years). GSUKX (0.83) is less costly to investors than VIHAX (0.16). GSUKX is a more actively managed with annual turnover of: 49.00 vs. VIHAX (9.00). VIHAX has a lower initial minimum investment than GSUKX: VIHAX (3000) vs GSUKX (5000000). VIHAX (25.96) and GSUKX (25.06) have marching annual gain over last year. GSUKX return over 5 years is better than : 89.27 vs. VIHAX (66.41).
GSUKXVIHAXGSUKX / VIHAX
Total Expense Ratio0.800.16500%
Annual Report Gross Expense Ratio0.830.16519%
Fund Existence10 years10 years-
Gain YTD16.70917.60195%
Front LoadN/AN/A-
Min. Initial Investment50000003000166,667%
Min. Initial Investment IRAN/AN/A-
Net Assets3.74B21.9B17%
Annual Yield % from dividends2.273.4566%
Returns for 1 year25.0625.9697%
Returns for 3 years81.5375.63108%
Returns for 5 years89.2766.41134%
Returns for 10 years166.56108.07154%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RMOCX19.250.23
+1.21%
Victory RS Mid Cap Growth C
CIVHX22.290.17
+0.77%
American Funds Intl Vntg 529-F-3
GSYPX45.930.22
+0.48%
Goldman Sachs Small Cap Value P
PASTX68.290.18
+0.26%
T. Rowe Price Science & Tech Adv
JMNCX12.25-0.01
-0.08%
JPMorgan Research Market Neutral C